FA
GH icon

Friess Associates’s Guardant Health GH Stock Holding History

Friess Associates’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-123,000
Closed -$10.6M – 118
2019
Q2 		$10.6M Buy
+123,000
New +$9.39M 0.77% 59
2019
Q1 		– Sell
-290,909
Closed -$10.9M – 134
2018
Q4 		$10.9M Buy
+290,909
New +$10.7M 0.93% 54

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Friess Associates's GH Position: Q3 2019 in Review

Friess Associates sold out of Guardant Health (GH) in Q3 2019, closing a stake of 123,000 shares — an estimated $10.6M sold.

Friess Associates first reported a position in GH in Q4 2018 and held it in 2 quarters. The position peaked at $10.9M in Q4 2018. 242 funds tracked by Wall St. Rank hold GH as of Q3 2019.

  • Friess Associates reported no remaining Guardant Health position as of Q3 2019 after selling out during the quarter.
  • Friess Associates sold 123,000 Guardant Health shares in Q3 2019, an estimated $10.6M.
  • Friess Associates first reported a position in Guardant Health in Q4 2018 and held it in 2 quarters.
  • Friess Associates's Guardant Health position peaked at $10.9M in Q4 2018.
  • 242 funds tracked by Wall St. Rank held Guardant Health as of Q3 2019.

Based on Friess Associates's 13F filing for Q3 2019, filed 14 Nov 2019.